488 related articles for article (PubMed ID: 35001784)
1. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
[TBL] [Abstract][Full Text] [Related]
3. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
4. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
6. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy.
Yu J; Zhang X; Pei Z; Shuai Q
J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960
[TBL] [Abstract][Full Text] [Related]
7. Iodinated Cyanine Dyes for Fast Near-Infrared-Guided Deep Tissue Synergistic Phototherapy.
Cao J; Chi J; Xia J; Zhang Y; Han S; Sun Y
ACS Appl Mater Interfaces; 2019 Jul; 11(29):25720-25729. PubMed ID: 31246000
[TBL] [Abstract][Full Text] [Related]
8. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
[TBL] [Abstract][Full Text] [Related]
9. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
11. Tumor Microenvironment-triggered Nanosystems as dual-relief Tumor Hypoxia Immunomodulators for enhanced Phototherapy.
Shen Z; Xia J; Ma Q; Zhu W; Gao Z; Han S; Liang Y; Cao J; Sun Y
Theranostics; 2020; 10(20):9132-9152. PubMed ID: 32802183
[TBL] [Abstract][Full Text] [Related]
12. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
[No Abstract] [Full Text] [Related]
13. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
[TBL] [Abstract][Full Text] [Related]
14. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
15. Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy.
Chi J; Ma Q; Shen Z; Ma C; Zhu W; Han S; Liang Y; Cao J; Sun Y
Nanoscale; 2020 May; 12(20):11008-11025. PubMed ID: 32301458
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.
Broekgaarden M; Weijer R; van Wijk AC; Cox RC; Egmond MR; Hoebe R; van Gulik TM; Heger M
J Biomed Nanotechnol; 2017 Feb; 13(2):204-20. PubMed ID: 29377650
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
[TBL] [Abstract][Full Text] [Related]
18. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
20. Ce6-Modified Carbon Dots for Multimodal-Imaging-Guided and Single-NIR-Laser-Triggered Photothermal/Photodynamic Synergistic Cancer Therapy by Reduced Irradiation Power.
Sun S; Chen J; Jiang K; Tang Z; Wang Y; Li Z; Liu C; Wu A; Lin H
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5791-5803. PubMed ID: 30648846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]